![]() |
|
|
Vol. 294, Issue 2, 627-632, August 2000
Department of Molecular and Integrative Physiology and R. L. Smith Mental Retardation Research Center, University of Kansas Medical
Center, Kansas City, Kansas
The effect of sympathectomy on parasympathetic regulation of ocular
perfusion was investigated. Uveal blood flow through the vortex veins
was measured by laser Doppler flowmetry during electrical stimulation
of the superior salivatory nucleus, which activates ocular
parasympathetic nerves, in adult rats with intact innervation and 2 days or 6 weeks after excision of the ipsilateral superior cervical
ganglion. In all groups, parasympathetic stimulation produced
comparable increases in flux, which were abolished by the selective
neuronal nitric-oxide synthetase inhibitor, 1-(2-trifluoromethylphenyl) imidazole. Atropine had no effect in control and acutely
sympathectomized rats but abolished the flux increase in four of six
chronically sympathectomized animals, and 1-(2-trifluoromethylphenyl)
imidazole eliminated the residual response. The muscarinic receptor
agonist bethanechol did not affect basal flow in control or
sympathectomized rats. However, bethanechol enhanced
parasympathetically mediated vasodilation, but only in rats studied at
6 weeks after sympathectomy, a finding consistent with the appearance
of muscarinic prejunctional facilitation of nitrergic transmission. In
chronically sympathectomized rats, the M2 and
M4 receptor antagonists methoctramine and tropicamide did
not affect choroidal flow during parasympathetic activation. However,
pirenzepine increased flux, implying the presence of M1
inhibitory autoreceptors on these nerves. Parasympathetically mediated
increased flux was partially blocked by the M3 antagonist 4-diphenylacetoxy-N-methylpiperdine, and the
remaining vasodilation was blocked by atropine. We conclude that
parasympathetic prejunctional facilitatory M3 and probably
M5 receptors adopt a crucial role after chronic
sympathectomy in maintaining nitrergic vasodilatory ocular
neurotransmission in the face of down-regulated nitric oxide
transmitter mechanisms.
This article has been cited by other articles:
![]() |
Y. Anini, T. Hansotia, and P. L. Brubaker Muscarinic Receptors Control Postprandial Release of Glucagon-Like Peptide-1: In Vivo and in Vitro Studies in Rats Endocrinology, June 1, 2002; 143(6): 2420 - 2426. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Douglas, H. A. Baghdoyan, and R. Lydic M2 Muscarinic Autoreceptors Modulate Acetylcholine Release in Prefrontal Cortex of C57BL/6J Mouse J. Pharmacol. Exp. Ther., December 1, 2001; 299(3): 960 - 966. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Hardy, D. Lamireau, X. Hou, I. Dumont, D. Abran, A.-M. Nuyt, D. R. Varma, and S. Chemtob Major role for neuronal NO synthase in curtailing choroidal blood flow autoregulation in newborn pig J Appl Physiol, October 1, 2001; 91(4): 1655 - 1662. [Abstract] [Full Text] [PDF] |
||||